New diabetes clinical trial: A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.

Published on: November 21, 2024 at 11:00PM
Conditions: Diabetic Macular Edema; Diabetic Retinopathy
Interventions: Drug: THN391 MAD
Sponsors: Therini Bio Pty Ltd
Not yet recruiting
https://ift.tt/rskHEet